phosphatidylcholines has been researched along with 6-methoxy-2-naphthylacetic acid in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (6-methoxy-2-naphthylacetic acid) | Trials (6-methoxy-2-naphthylacetic acid) | Recent Studies (post-2010) (6-methoxy-2-naphthylacetic acid) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 61 | 6 | 13 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | 6-methoxy-2-naphthylacetic acid (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 4.113 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.65 | |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 1.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devkar, RV; Gajaria, TK; Manjappa, AS; Mishra, AK; Murumkar, PR; Pawar, VA; Yadav, MR | 1 |
1 other study(ies) available for phosphatidylcholines and 6-methoxy-2-naphthylacetic acid
| Article | Year |
|---|---|
Drug-fortified liposomes as carriers for sustained release of NSAIDs: The concept and its validation in the animal model for the treatment of arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cartilage, Articular; Cell Survival; Delayed-Action Preparations; Fatty Acids, Monounsaturated; Liposomes; Male; Mice; Naphthaleneacetic Acids; NIH 3T3 Cells; Phosphatidylcholines; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Rats, Sprague-Dawley | 2018 |